HHOW has quickly become recognized as a leader in funding of pediatric cancer research in the U.S. More than 780 grants have been awarded over the past 19 years. In fact, there are over 280 HHOW research projects currently underway. For 2017, we will announce an additional 68 pediatric cancer research grants. A HHOW research grant is awarded to an institution that is member of the Children's Oncology group of America (COG) and the doctor-researcher within these institutions is doing research in pediatric oncology, which has a translational benefit to patients. Grant applicants are invited to submit a research proposal once a year. These proposals are peer-reviewed by a scientific panel and funded grants are selected based on their innovation to the field and ability to have the greatest impact on improving cures. There are 4 HHOW grant categories:
- The Hyundai Impact Award ($50,000): a one-year grant awarded to the pediatric cancer oncology department at children's hospitals in the U.S. Funds may be used to provide programmatic support or clinician for patient care at the center.
- The Young Investigator Grant ($150,000): a two-year grant, which is peer-reviewed and competitively selected. The grant supports the work of a pediatric oncologist, who is within his/her first 7 years of practice at an academic institution and is doing translational research.
- The Hyundai Scholar Hope Grant ($250,000): a two-year grant, which is peer-reviewed and competitively selected. The grant supports the work of a pediatric oncologist, who is an MD physician-researcher at any level of his/her career at any COG member institution and is doing translational research.
- The Hyundai Quantum Award ($1 million): a four-year grant, which is for a peer-reviewed and competitively selected. This grant is awarded to a pediatric oncologist, who is an MD physician-researcher, for advanced research projects that focus on high risk pediatric cancers with low survival rates.